BioLamina (Stockholm, Sweden) is a company developing, producing and marketing tools that help scientists handle different types of primary cells including stem cells. One of the main products is LN-521™, a human recombinant laminin-521, which has now shown to solve several critical technical problems that have been delaying or even blocking the development of cell therapy and regenerative medicine.Only a few clinical trials have so far been performed with cells of embryonic stem cell origin since they were first isolated in 1998.
No comments:
Post a Comment